Gregor Tuschl

1.4k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Gregor Tuschl is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Gregor Tuschl has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Gregor Tuschl's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Gregor Tuschl is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Gregor Tuschl collaborates with scholars based in Germany, France and Switzerland. Gregor Tuschl's co-authors include Stefan O. Mueller, Jan G. Hengstler, J. Gerry Kenna, David Hallifax, Christian Skonberg, Lena Gustavsson, Nicola J. Hewitt, Patrick Maurel, Albert P. Li and Hayley S. Brown and has published in prestigious journals such as Hepatology, Toxicology and Applied Pharmacology and Toxicology.

In The Last Decade

Gregor Tuschl

14 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

2007 530 citations Nicola J. Hewitt, María José Gómez Lechón et al. Drug Metabolism Reviews profile →

Peers

Gregor Tuschl

HEPAT

PHARM

ONCOL

Kajsa P. Kanebratt Sweden

Eliane Alexandre France

Ruoya Li France

María José Gómez Lechón Spain

B. O. Depelchin Belgium

Paul M. Silber United States

Donna Li United States

Teija Oinonen Finland

Henk Koster Netherlands

Thomas K. Baker United States

Kajsa P. Kanebratt Sweden

Gregor Tuschl

271 ×0.7

HEPAT

556 ×1.4

PHARM

412 ×1.4

307 ×1.1

ONCOL

328 ×1.3

Citations per year, relative to Gregor Tuschl Gregor Tuschl (= 1×) peers Kajsa P. Kanebratt

Countries citing papers authored by Gregor Tuschl

Since Specialization

Citations

This map shows the geographic impact of Gregor Tuschl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Tuschl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Tuschl more than expected).

Fields of papers citing papers by Gregor Tuschl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Tuschl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Tuschl. The network helps show where Gregor Tuschl may publish in the future.

Co-authorship network of co-authors of Gregor Tuschl

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Tuschl. A scholar is included among the top collaborators of Gregor Tuschl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Tuschl. Gregor Tuschl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Clemann, Nicole, et al.. (2024). Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach. Regulatory Toxicology and Pharmacology. 150. 105649–105649. 3 indexed citations

Bercu, Joel P., Alejandra Trejo‐Martin, Robert A. Jolly, et al.. (2023). Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs). Regulatory Toxicology and Pharmacology. 142. 105415–105415. 24 indexed citations

Hawkins, W. Anthony, et al.. (2020). Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2. Regulatory Toxicology and Pharmacology. 115. 104692–104692. 5 indexed citations

Tuschl, Gregor, et al.. (2019). What to consider for a good quality PDE document?. Pharmaceutical Development and Technology. 24(7). 803–811. 5 indexed citations

Mueller, Stefan O., et al.. (2009). Species-specific activation of nuclear receptors correlates with the response of liver drug metabolizing enzymes to EMD 392949 in vitro. Toxicology Letters. 193(1). 120–123. 8 indexed citations

Tuschl, Gregor, et al.. (2009). Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: A valuable model for in vitro toxicity and drug–drug interaction studies. Chemico-Biological Interactions. 181(1). 124–137. 74 indexed citations

Godoy, Patrício, Jan G. Hengstler, Iryna Ilkavets, et al.. (2009). Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis†. Hepatology. 49(6). 2031–2043. 159 indexed citations

Tuschl, Gregor, et al.. (2008). Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opinion on Drug Metabolism & Toxicology. 4(7). 855–870. 46 indexed citations

Tuschl, Gregor, et al.. (2008). Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chemico-Biological Interactions. 179(1). 17–24. 71 indexed citations

10.

Richert, Lysiane, Gregor Tuschl, Catherine Viollon‐Abadie, et al.. (2008). Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro. Drug Metabolism and Disposition. 36(4). 702–714. 23 indexed citations

11.

Richert, Lysiane, Gregor Tuschl, Catherine Abadie, et al.. (2008). Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicology and Applied Pharmacology. 235(1). 86–96. 41 indexed citations

12.

Hewitt, Nicola J., María José Gómez Lechón, J. Brian Houston, et al.. (2007). Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. Drug Metabolism Reviews. 39(1). 159–234. 530 indexed citations breakdown →

13.

Mueller, Stefan O., et al.. (2007). Alternatives in pharmaceutical toxicology: Global and focussed approaches - Two case studies. ALTEX. 24(2). 117–24. 1 indexed citations

14.

Tuschl, Gregor & Stefan O. Mueller. (2005). Effects of cell culture conditions on primary rat hepatocytes—Cell morphology and differential gene expression. Toxicology. 218(2-3). 205–215. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact